What is it about?
Recognition of DKD as an inflammatory disease linked to metabolic perturbations is a central tenet that requires broader and deeper exploration. Glycemic variability may be a DKD risk factor through mechanisms involving KIM-1 on circulating T cells that infiltrate the kidney.
Featured Image
Read the Original
This page is a summary of: Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney, Diabetes, August 2021, American Diabetes Association,
DOI: 10.2337/dbi21-0021.
You can read the full text:
Contributors
Be the first to contribute to this page
